HANOVER, N.H.--(BUSINESS WIRE)--Adimab LLC, a leader in the discovery of fully human antibodies, today announced that Frances K. Heller has been appointed to its Board of Directors. Ms. Heller is the Executive Vice President of Business Development of Exelixis, Inc. (Nasdaq: EXEL) and is an acknowledged life sciences business development leader, having led or participated in nearly 100 transactions over the course of her career.
